Aviva PLC increased its stake in Perrigo Company plc (NYSE:PRGO) by 1.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 45,391 shares of the company’s stock after purchasing an additional 523 shares during the quarter. Aviva PLC’s holdings in Perrigo were worth $1,837,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Allianz Asset Management GmbH raised its holdings in Perrigo by 100.0% during the 1st quarter. Allianz Asset Management GmbH now owns 12,118 shares of the company’s stock valued at $490,000 after acquiring an additional 6,060 shares during the period. Altshuler Shaham Ltd bought a new stake in Perrigo during the 1st quarter valued at $575,000. Ergoteles LLC raised its holdings in Perrigo by 1,696.6% during the 1st quarter. Ergoteles LLC now owns 146,354 shares of the company’s stock valued at $5,923,000 after acquiring an additional 138,208 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in Perrigo by 7.3% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,382,532 shares of the company’s stock valued at $56,053,000 after acquiring an additional 93,485 shares during the period. Finally, Financial Engines Advisors L.L.C. bought a new stake in Perrigo during the 1st quarter valued at $205,000. 85.72% of the stock is currently owned by institutional investors.
A number of equities research analysts have issued reports on PRGO shares. Morgan Stanley lowered their target price on shares of Perrigo from $53.00 to $45.00 and set an “equal weight” rating on the stock in a report on Friday, March 5th. Royal Bank of Canada assumed coverage on shares of Perrigo in a research report on Wednesday, April 7th. They set a “sector perform” rating and a $51.00 price target for the company. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $52.00.
Perrigo (NYSE:PRGO) last released its quarterly earnings results on Monday, May 10th. The company reported $0.50 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.07). The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Perrigo had a negative net margin of 4.88% and a positive return on equity of 8.06%. The firm’s revenue for the quarter was down 6.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.14 earnings per share. Research analysts forecast that Perrigo Company plc will post 2.6 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 22nd. Investors of record on Friday, June 4th were given a $0.24 dividend. The ex-dividend date of this dividend was Thursday, June 3rd. This represents a $0.96 annualized dividend and a yield of 2.08%. Perrigo’s dividend payout ratio (DPR) is presently 23.88%.
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments.
Read More: Capital gains and your 401(k) or IRA
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.